Multiparametric magnetic resonance imaging and clinical variables: Which is the best combination to predict reclassification in active surveillance patients?-Reference-Cited by-同舟云学术

Multiparametric magnetic resonance imaging and clinical variables: Which is the best combination to predict reclassification in active surveillance patients?

Published:2020-12 Issue:4 Volume:8 Page:167-172
ISSN:2287-8882
Container-title:Prostate International
language:en
Short-container-title:Prostate International

Author:

Roscigno Marco,Stabile Armando,Lughezzani Giovanni,Pepe Pietro,Dell’Atti Lucio,Naselli Angelo,Naspro Richard,Nicolai Maria,La Croce Giovanni,Muhannad Aljoulani,Perugini Giovanna,Guazzoni Giorgio,Montorsi Francesco,Balzarini Luca,Sironi Sandro,Da Pozzo Luigi F.

Publisher

Elsevier BV

Subject

Urology

Reference24 articles.

1. Clinically Localized Prostate Cancer,2019

2. Active surveillance for the management of localized prostate cancer: Guideline recommendations;Morash;Can Urol Assoc J,2015

3. Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancerx;Suardi;BJU Int,2010

4. The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy;Lee;Eur Urol,2010

5. Movember GAP3 consortium. Active surveillance for prostate cancer: a narrative review of clinical guidelines;Bruinsma;Nat Rev Urol,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Values of multiparametric and biparametric MRI in diagnosing clinically significant prostate cancer: a multivariate analysis;BMC Urology;2024-02-16

2. Significant Prostate Cancer in Patients with PI-RADS Category 3 Lesions: A Single-Center, Retrospective Cohort Study;UROL J;2023

3. 68Ga-PSMA PET/CT evaluation in men enrolled in prostate cancer Active Surveillance;Archivio Italiano di Urologia e Andrologia;2023-05-22

4. Could 68Ga-PSMA PET/CT Evaluation Reduce the Number of Scheduled Prostate Biopsies in Men Enrolled in Active Surveillance Protocols?;Journal of Clinical Medicine;2022-06-16

5. PI-RADS v2.1 Combined With Prostate-Specific Antigen Density for Detection of Prostate Cancer in Peripheral Zone;Frontiers in Oncology;2022-04-08